Scientists seek 10 years of patient records to unlock asthma secrets
NCT ID NCT03152669
First seen Jun 26, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This study aims to collect up to 10 years of electronic medical records and a one-time questionnaire from over 1,100 asthma and COPD patients who previously took part in the Salford Lung Study. The goal is to better understand how these lung diseases progress and how treatments work over the long term. No new drugs or treatments are being tested—this is purely about gathering data to improve scientific knowledge.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a rich dataset to improve understanding of asthma and COPD, potentially guiding better treatments and care.
- What could go wrong
- This is an observational data collection study, not a treatment trial. It was terminated early, so the full dataset may not be available, limiting conclusions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Manchester, M274AF, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI and a smartphone app may let kids with asthma skip clinic visits
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Short steroid course after first wheeze may stop asthma before it starts
- New antibody drug aims to tame Hard-to-Control asthma
- New asthma drug aims to improve breathing without daily pills
- Scientists compare two formulations of a potential asthma treatment